Japanese Firm Finalizes Record-Setting $1.1 Billion Acquisition of Israel’s NeuroDerm | Algemeiner
JNS.org – Following announcements in July that Japan’s Mitsubishi Tanabe Pharma Corporation (MTPC) would acquire the Israeli pharmaceutical company NeuroDerm for $1.1 billion, the companies announced the deal’s finalization on Wednesday.
Hinterlasse eine Antwort
Sie müssen... (sein)angemeldet sein um einen Kommentar zu schreiben.